Lectures
2009
Francis JL. The Hypercoagulable State. Gateway to the Brain, Orlando FL, January 20, 2009.
Francis JL. Hypercoagulable States. Winter Park Hospital CME Program Series, Winter Park FL, February 24, 2009.
Francis JL and Moroose R. The Clot Thickens. Internal medicine Grand Rounds, Florida Hospital, Orlando, FL, March 4, 2009.
Francis JL. Heparin-Induced Thrombocytopenia. Critical care Advisory Board, Instrumentation Laboratories, Wellesley, MA, May 7, 2009.
Francis JL. Hypercoagulable States. Northeast Symposium on Current Concepts in Coagulation, Uncasville, CT, May 21, 2009.
2008
Francis JL. Blood Coagulation and Cancer. Sparrow Hospital Cancer Center CME Program. Lansing, MI, April 18, 2008.
Drexler A. A Lesson from Broadway: Setting the Stage for Successful Research Projects through Protocol Feasibility. Association of Clinical Research Professionals (ACRP) Global Conference & Exhibition, Boston, MA, April 25 - 29, 2008.
Francis JL. Clinical applications of the PFA-100 Analyzer. Anatomic and Clinical Pathology Update. University of Louisville, Louisville, KY. May 15-17, 2008.
Francis JL. Update on Blood Coagulation. ASCP Workshop, San Francisco, July 29, 2008.
Francis JL. Update on Blood Coagulation. ASCP Workshop, Minneapolis, September 12, 2008.
2007
Francis JL. Update on Blood Coagulation. ASCP Workshop, Chicago, April 20, 2007.
Francis JL. Laboratory diagnosis of heparin-induced thrombocytopenia. Mayo Clinic – NASCOLA Annual Symposium, Rochester, MN, April 26, 2007.
Francis JL. Assessment of resistance to anti-platelet drugs. MidWest Coagulation symposium. Indianapolis, May 4, 2007.
Francis JL. Laboratory Control of Heparin Therapy. San Juan, PR, May 10, 2007.
Francis JL. Hemostasis and Cancer. Spring Series Hemostasis Symposium, Dade-Behring Inc., Charleston, SC, May 23, 2007.
Amirkhoshravi A. Therapeutic Antibody-Induced Platelet Activation. Gordon Conference, Boston, MA, June 12, 2007.
Francis JL. Heparin-Induced thrombocytopenia. Bayer Pharmaceuticals, Jacksonville, FL, June 19, 2007.
Francis JL. Laboratory Diagnosis of Thrombophilia. Dade-Behring Teleconference, Orlando, FL, June 21, 2007.
Francis JL. Heparin-Induced Thrombocytopenia, Bayer Pharmaceuticals, Orlando, FL, June 21, 2007.
Francis JL. Hemostasis and Cancer. Fall Series Hemostasis Symposium, Dade-Behring Inc., Napa, CA, September 19, 2007.
Francis JL. Global Assessment of Coagulation. National Hemophilia Foundation, Orlando, FL, November 2, 2007.
2006
Francis JL. Testing for Heparin-Induced Thrombocytopenia. Instrumentation Laboratories, Lexington, MA, January 19, 2006.
Francis JL. Anti-Cancer Properties of Low Molecular Weight Heparin. Grand Rounds, Florida Hospital Celebration Health, March 1, 2006.
Francis JL. Overview of Hemostasis. Workshop in Hemostasis and Thrombosis: American Society for Clinical Pathology, Baltimore, MD, May 5, 2006.
Francis JL. Laboratory Testing for Hemostatic Defects. Workshop in Hemostasis and Thrombosis: American Society for Clinical Pathology, Baltimore, MD, May 5, 2006.
Francis JL. Antiplatelet and Anticoagulant Therapy. Workshop in Hemostasis and Thrombosis: American Society for Clinical Pathology, Baltimore, MD, May 5, 2006.
Francis JL. Thrombophilia. Workshop in Hemostasis and Thrombosis: American Society for Clinical Pathology, Baltimore, MD, May 5, 2006.
Francis JL. Clinical Applications of Whole Blood Coagulation Testing with the Thromboelastograph Analyzer. Florida Coalition of Professional Laboratory Organizations 2006 Annual Exhibition and Conference, Orlando, FL, May 6, 2006.
Francis JL. Mechanisms of Clotting Activation in Cancer. American Society of Clinical Oncology Annual Meeting – “Trousseau’s legacy: Malignancy and Thromboembolic Disease. Atlanta, GA, June 6, 2006.
Francis JL. Hemostasis and Cancer. Novacea Inc., San Francisco, CA, August 7, 2006.
Francis JL. Emerging Trends in Anticoagulant Therapy in the Surgical Patient. Emerging Trends in Interventional Cardiology. Royal Pacific Hotel, Orlando, FL, August 13, 2006.
Francis JL. Clinical Applications of the PFA-100. Dade Days Symposium, Orlando, FL, September 19, 2006.
Francis JL. Hemostasis and Cancer. Dade Days Symposium, Orlando, FL, September 19, 2006.
Francis JL. Clinical Applications of the PFA-100. Dade Days Symposium, Deerfield Beach, FL, September 21, 2006.
Francis JL. Hemostasis and Cancer. Dade Days Symposium, Deerfield Beach, FL, September 21, 2006.
Francis JL. Clinical Applications of the PFA-100. Dade-Behring Fall Series Symposium, Las Vegas, NV, September 27, 2006.
Francis JL. Coagulation and Cancer. St. Louis University Coagulation Consultants 20th Annual Symposium - Advances in Hemostasis and Thrombosis. St. Louis, MO, November 2, 2006.
Francis JL. Clinical Applications of the PFA-100. CME Program. Doctors’ Baptist Hospital, Miami, FL, November 13, 2006.
Francis JL. Coagulation and Cancer. .Coagulation Symposium – Diagnostica Stago. Denver, CO, November 15, 2006.
Francis JL. Applications of the Thromboelastograph analyzer. 6th Annual HealthFirst Point-of-Care Conference, Cocoa Beach, FL, November 17, 2006.
2005
Francis JL. Testing for heparin antibodies. Cardiovascular Surgery Consultants’ Meeting, The Medicines Company, Miami, FL January 13, 2005.
Francis JL. Clinical applications of the Platelet Function Analyzer (PFA)-100. Dade-Behring Spring Hemostasis Series, Mystic, CT, April 13, 2005.
Francis JL. Clinical applications of the Platelet Function Analyzer (PFA)-100. Dade-Behring Spring Hemostasis Series, Mystic, CT, April 14, 2005.
Francis JL. Is there such a thing as asymptomatic heparin antibodies? Preventing Heparin Induced Thrombocytopenia. Advisory Board Meeting. The Medicines Company, Orlando, FL, May 7, 2005.
Francis JL. Pathophysiology and Diagnosis of Heparin-Induced Thrombocytopenia. Dade Days Symposium, Nashville, TN, August 25, 2005.
Francis JL. Pathophysiology and Diagnosis of Heparin-Induced Thrombocytopenia. Dade-Behring Hemostasis Fall Series Symposium, Scottsdale, AZ, September 14, 2005.
Francis JL. Pathophysiology and Diagnosis of Heparin-Induced Thrombocytopenia. Family Practice Residency Program Lecture. Orlando, FL, November 23, 2005.
2004
Francis JL. Heparin-Induced Thrombocytopenia: Update on Diagnosis and Management. Understanding the Impact of HIT: A Scientific Conference & Publication Program. Amelia Island Plantation, Amelia Island, FL, January 16-18, 2004.
Francis JL. Diagnosis and Management of Heparin-Induced Thrombocytopenia. Satellite Symposium - International Stroke Conference, San Diego, CA, February 6th, 2004.
Francis JL. Heparin-induced Thrombocytopenia: Pathophysiology, Diagnosis and Management. Visiting Distinguished Professor - Pathology Grand Rounds. Emory University Medical Center, Atlanta, GA, February 18, 2004.
Francis JL. Heparin-Induced Thrombocytopenia, 33rd Annual Conference, Society for Critical Care Medicine, Gaylord Palms Hotel, Orlando, FL, February 22, 2004.
Francis JL. New Applications of the PFA-100. Dade Days Symposium, Orlando, FL, February 24, 2004.
Francis JL. New Applications of the PFA-100. Dade Days Symposium, Deerfield Beach, FL, February 26, 2004.
Francis JL. Update on Hemostasis and New Anticoagulant Drugs. Florida Association of Hospital Pharmacists, Tampa, FL, February 26, 2004.
Francis JL. Hemostatic Pathways. Bayer Corporation - Invited Speaker, Berkeley, CA, March 1st, 2004.
Francis JL. Heparin-Induced Thrombocytopenia. Sarasota Memorial Hospital Pharmacy Department. Sarasota, FL, March 12, 2004.
Francis JL. Challenges with unfractionated heparin. Variations in responsiveness. National Scientific Education Panel, University Pharmacotherapy Associates, Sanibel, FL, April 16-18, 2004.
Francis JL. Update on Hemostasis and New Anticoagulant Drugs, Florida Coalition of Professional Laboratories Organization, Fort Lauderdale, FL, May 7, 2004.
Francis JL. Advances in Platelet Function testing: Heparin-Induced Thrombocytopenia and Aspirin Resistance, Mid-West Hemostasis Conference, Indianapolis, IN, May 13, 2004.
Francis JL. Applications of the PFA-100, Dade Hemostasis Spring Series, San Antonio, TX, May 19, 2004.
Francis JL. Testing for heparin antibodies, Hematology Advisory Board, The Medicines Company, New York City, NY, May 21-23, 2004.
Francis JL. The Florida Hospital Registry of Bivalirudin in HIT, Hematology Advisory Board, The Medicines Company, New York City, NY, May 21-23, 2004.
Francis JL. Testing for heparin antibodies, Hematology Advisory Board, The Medicines Company, San Francisco, CA, NY, June 10-12, 2004.
Francis JL. The Florida Hospital Registry of Bivalirudin in HIT, Hematology Advisory Board, The Medicines Company, San Francisco, CA, NY, June 10-12, 2004.
Francis JL. Laboratory Diagnosis of Heparin-Induced Thrombocytopenia. Dade Days Symposium. New Orleans, LA, June 17, 2004.
Francis JL. Mechanisms and Laboratory Manifestations of Coagulation Activation in Cancer. Supportive Care in Cancer, Miami, FL, June 26, 2004.
Francis JL. Overview of Hemostasis. Workshop in Hemostasis and Thrombosis: American Society for Clinical Pathology, Teaneck, NJ, June 29, 2004.
Francis JL. Laboratory Testing for Hemostatic Defects. Workshop in Hemostasis and Thrombosis: American Society for Clinical Pathology, Teaneck, NJ, June 29, 2004.
Francis JL. Antiplatelet and Anticoagulant Therapy. Workshop in Hemostasis and Thrombosis: American Society for Clinical Pathology, Teaneck, NJ, June 29, 2004.
Francis JL. Thrombophilia. Workshop in Hemostasis and Thrombosis: American Society for Clinical Pathology, Teaneck, NJ, June 29, 2004.
Francis JL. Bleeding Time and Platelet Function Analyzer-100: An Update. Mayo Bleeding and Thrombosing Diseases Conference and Wet Workshop. Rochester, MN, August 6, 2004.
Francis JL. Hypercoagulability - The Hidden Threat. Dade Behring Fall Hemostasis Symposium, Tampa, FL, September 21, 2004.
Francis JL. New Applications of the PFA-100. Dade Days Symposium, Philadelphia, PA, September 28, 2004.
Francis JL. Heparin-Induced Thrombocytopenia. CME program sponsored by The Medicines Company. Charlotte, NC, October 11, 2004.
Francis JL. Heparin-Induced Thrombocytopenia. Grand Rounds Presentation, Gaston Memorial Hospital, Gaston, NC, October 12, 2004.
Francis JL. Making the Diagnosis of Heparin-Induced Thrombocytopenia. The 18th Annual Kjeldgaard Day Symposium - Heparin-Induced Thrombocytopenia. Maine Medical Center, Portland, ME, October 13, 2004.
Francis JL. Tissue Factor and Cancer. Summit Meeting on rNAPc2, Boston, MA, October 16-17, 2004.
Francis JL. Effective Presentations. Leadership Development Course, Adventis Health Systems Corporate Offices, Orlando, FL, October 21, 2004.
Francis JL. Heparin-Induced Thrombocytopenia. North East District - Georgia Society of Health System Pharmacists, Athens, GA, November 1, 2004.
Francis JL. Coagulation and cancer: Emerging roles of Tissue Factor. Pathology Grand Rounds, Loyola University, Chicago, IL. November 18, 2004.
Francis JL. Heparin-Induced Thrombocytopenia. CME program sponsored by The Medicines Company. Houston, TX, November 29, 2004.
Francis JL. Heparin antibodies: What do they mean? What's happening with HIT: Emerging Preventive, Diagnostic and Management Strategies. Corporate Friday Symposium, American Society for Hematology 46th Annual Meeting, San Diego, CA, December 3, 2004.
2003
Francis JL. Heparin-induced thrombocytopenia: Pathophysiology, diagnosis and management. Sanford Regional Hospital, Sanford, FL, March 13th, 2003.
Francis JL. Use of bivalrudin for the treatment of heparin-induced thrombocytopenia. Angiomax Hematology Consultant's Meeting, Ponte Vedra, FL, March 14th, 2003.
Francis JL. Overview of hemostasis. American Society for Clinical Pathology. Workshops for Laboratory Professionals. San Francisco, CA, March 20, 2003.
Francis JL. Laboratory Investigation of Bleeding Disorders. American Society for Clinical Pathology. Workshops for Laboratory Professionals. San Francisco, CA, March 20, 2003.
Francis JL. Antiplatelet and Anticoagulant Therapy. American Society for Clinical Pathology. Workshops for Laboratory Professionals. San Francisco, CA, March 20, 2003.
Francis JL. Thrombophilia. American Society for Clinical Pathology. Workshops for Laboratory Professionals. San Francisco, CA, March 20, 2003.
Francis JL. Blood Coagulation and Cancer. Pharmacy Department, Roper Hospital, Charleston, SC, March 24, 2003.
Francis JL. Blood Coagulation and Cancer. Pharmacy Department, VA Hospital, Charleston, SC, March 24, 2003.
Francis JL. Blood Coagulation and Cancer. CME Program sponsored by Pharmion, Inc, Charleston, SC, March 24, 2003.
Francis JL. Blood Coagulation and Cancer. Pharmacy Department, Durham VA Medical Center, Raleigh-Durham, NC, March 26, 2003.
Francis JL. Heparin antibodies. Investors' Meeting. The Medicines Company, Chicago, IL, March 30, 2003.
Francis JL. Laboratory Investigation of Platelet Function Defects. Hemostasis and Thrombosis Update - 20th Annual Seminar and Workshop. Temple University School of Medicine, Philadelphia, PA, April 24, 2003.
Francis JL. Heparin Antibodies in Cardiovascular Medicine. Optimizing Anticoagulation and Improving Outcomes in Patients Undergoing Cardiac Surgery. CME Program, Vanderbilt University School of Medicine. Society of Cardiovascular Anesthesia Meeting, Miami, FL, April 26, 2003.
Francis JL. Heparin-Induced Thrombocytopenia - Implications for Emergency Medicine. Orlando Regional Medical Center, Orlando, FL, April 29, 2003.
Francis JL. Heparin-induced Thrombocytopenia: Pathophysiology, Diagnosis and Management. Osceola Medical Center, Kissimmee, FL. April 30, 2003.
Francis JL. Applications of the Platelet Function Analyzer. CME Program. Baptist Hospital. Miami, FL, May 6, 2003.
Francis JL. Blood Coagulation and Cancer. Pharmacy Department, Bay Pines VA Medical Center, St. Petersberg, FL, May 12, 2003.
Francis JL. Algorithmic Approach to the Diagnosis of Hypercoagulability. International Society for Laboratory Hematology. Orlando, FL, May 15, 2003.
Francis JL. Laboratory Diagnosis of Hypercoagulability. Dade-Behring Spring Series in Hemostasis. Raleigh-Durham, NC, May 21, 2003.
Francis JL. Hemostasis and Cancer. Pharmion Corporation, Orlando, FL, June 11, 2003.
Francis JL. Bivalirudin in the treatment of heparin-induced thrombocytopenia. The Medicines Company. Charleston, WV, June 25, 2003.
Francis JL. Methods for the Analysis of Tissue Factor in Cells and Biological Fluids. 49th Meeting of the Scientific and Standardization Committee of the ISTH. Birmingham, England, July 13th, 2003.
Francis JL. Frequency of heparin antibodies in patients presenting to the ER. Symposium: "HIT: What do we know about this immune reaction". Birmingham, England, July 15th, 2003.
Francis JL. Hemostasis and Cancer. Florida Association of Physician Assistants. St. Petersberg, FL, August 6, 2003.
Francis JL. Treatment of heparin-induced thrombocytopenia. SECAPS 2003, Nashville, TN, September 13, 2003.
Francis JL. Heparin-induced thrombocytopenia in the Emergency Room and Critical Care Medicine. GlaxoSmithKline Speakers' Training Meeting. September 30, 2003.
Francis JL. Clinical applications of the PFA-100 Platelet Function Analyzer. 3rd Annual Southwest Symposium on Thrombosis, Hemostasis and Transfusion Medicine. Albuquerque, New Mexico, October 3-4, 2003.
Francis JL. Heparin-induced thrombocytopenia in the Emergency Room. Satellite Symposium, American College of Emergency Physicians, Boston, October 12, 2003.
Francis JL. Clinical Applications of the PFA-100 Platelet Function Analyzer. Dade Days Symposium, New Orleans, LA, October 23, 2003.
Francis JL. Monitoring heparin therapy. Consensus on Contemporary UFH Issues: Challenges in Variation and Responsiveness. University Pharmacotherapy Associates, Pittsburgh, PA, October 30, 2003.
Francis JL. Bivalirudin in the treatment of heparin-induced thrombocytopenia. ACCP Symposium "Redefining Anticoagulation in Cardiovascular Disease: The Emerging Role of Direct Thrombin Inhibitors", Atlanta, GA, November 1, 2003.
Francis JL. Bivalirudin in the treatment of heparin-induced thrombocytopenia. The Medicines Company, San Diego, CA, December 6, 2003.
2002
Francis JL. Replacing heparin in cardiovascular surgery. "Expanding the Role of Direct Thrombin Inhibitors to Improve Patient Outcomes", ACPE Accredited Satellite Symposium, 37th ASHP Midyear Clinical Meeting, Atlanta, GA, December 9, 2002.
Francis JL. Heparin-induced thrombocytopenia: Pathophysiology, diagnosis and management. Round Table Discussion.Ritz-Carlton Hotel, Atlanta, GA, December 8, 2002.
Francis JL. How blood clots - and why it sometimes doesn't. Advances in Pediatric Hematology/Oncology. Florida Pediatric Tumor Association. Caribe Royale Resort, Orlando, FL, November 14th, 2002.
Francis JL. Laboratory investigation of the hypercoagulable state. Dade Daze Symposium - Sponsored by Dade-Behring Inc., Orlando, FL, November 14th, 2002.
Francis JL. Laboratory investigation of the hypercoagulable state. Dade Daze Symposium - Sponsored by Dade-Behring Inc., Deerfield Beach, FL, November 12th, 2002.
Francis JL. Applications of the Platelet Function Analyzer. Dade Daze Symposium - Sponsored by Dade-Behring Inc., Deerfield Beach, FL, November 12th, 2002.
Francis JL. Applications of the Platelet Function Analyzer. Dade Daze Symposium - Sponsored by Dade-Behring Inc., Birmingham, AL, November 7th, 2002.
Francis JL. Applications of the Platelet Function Analyzer. Dade Daze Symposium - Sponsored by Dade-Behring Inc., Jackson, MS, November 6th, 2002.
Francis JL. Applications of the Platelet Function Analyzer. Dade Daze Symposium - Sponsored by Dade-Behring Inc., Lafayette, LA, November 5th, 2002.
Francis JL. Hypercoagulability. Aventis Pharmaceuticals, Melbourne, FL, October 16th, 2002.
Francis JL. Clinical applications of the PFA-100. CME Lecture, JFK Medical Center, Hollywood, FL, October 8th, 2002.
Francis JL. Hemostasis and Cancer. Pat Reynolds 18th Annual Chemotherapy Update Course, Hard Rock Resort Hotel, Orlando, FL, October 6th, 2002.
Francis JL. Clinical applications of the PFA-100. Dade-Behring "Dade Daze" Symposium, Denver, CO, October 4th, 2002.
Francis JL. Hemostasis and Cancer. Pharmion Inc., Innohep® Launch Meeting, Vail, CO, October 1st, 2002
Francis JL. Clinical applications of the PFA-100. Screening for von Willebrand's Disease in menorrhagia and aspirin resistance. Dade-Behring Fall Hemostasis Series, Las Vegas, NV, September 25th, 2002.
Francis JL. Clinical application and implementation of the PFA-100. CME Lecture, Delray Medical Center, Delray Beach, FL, September 17th, 2002.
Francis JL. Clinical application and implementation of the PFA-100. Dade-Behring Inc., Mount Vernon Medical Center, IL, September 13th, 2002.
Francis JL. Pathogenesis, diagnosis and management of heparin-induced thrombocytopenia. The Medicines Company. Nashville, TN, August 29th, 2002.
Francis JL. Clinical application and implementation of the PFA-100. Dade-Behring Teleconference, Orlando, FL, July 10th, 2002.
Francis JL. Effects of modulating hemostasis on experimental metastasis. Symposium on Hemostasis, Cancer and Angiogenesis, Asheville, NC, June 22nd, 2002.
Francis JL. Pathogenesis and diagnosis of heparin-induced thrombocytopenia. The Medicines Company, Chicago, IL, June 5th, 2002.
Francis JL. Pathogenesis, diagnosis and management of heparin-induced thrombocytopenia. The Medicines Company, Consultant’s Meeting, Sawgrass, FL, May 5th, 2002.
Francis JL. Clinical applications of the Platelet Function Analyzer (PFA)-100. Dade Behring Inc., 2002 Hemostasis Spring Diagnostic Conference, Cleveland, OH, April 24th, 2002.
Francis JL. Overview of platelet function testing. Florida Coalition of Professional Laboratory Organizations, Orlando, FL, April 13th, 2002.
Francis JL. Pathogenesis, diagnosis and management of heparin-induced thrombocytopenia. The Medicines Company, Consultant’s Meeting, San Francisco, CA, April 7th, 2002.
Francis JL. Pathogenesis, diagnosis and management of heparin-induced thrombocytopenia. CME Lecture. Heartland Hospital, Sebring, FL, March 27th, 2002.
Francis JL. Hemostasis and Cancer. Sigma Diagnostics "Be a Believer" Symposium, Tampa, FL, March 15th, 2002.
Francis JL. Pathogenesis, diagnosis and management of heparin-induced thrombocytopenia. Sigma Diagnostics "Be a Believer" Symposium, Tampa, FL, March 15th, 2002.
Francis JL. Pathogenesis, diagnosis and management of heparin-induced thrombocytopenia. The Medicines Company, Consultant’s Meeting, Naples, FL February 23rd, 2002.
2001
Francis JL. Application of thromboelastography to study clot formation and structure. Corporate Friday Symposia, American Society of Hematology, Orlando, FL, December 7th, 2001.
Francis JL. Pathogenesis, diagnosis and management of heparin-induced thrombocytopenia. Medical Education Systems CME, Winson Salem, NC, December 3rd, 2001.
Francis JL. Pathogenesis, diagnosis and management of heparin-induced thrombocytopenia. Medical Education Systems CME, West Orange, NJ, November 27th, 2001.
Francis JL. Clinical applications of the Platelet Function Analyzer (PFA-100). Sysmex UK User Group 10th Annual Meeting, Birmingham, UK, November 1st, 2001.
Francis JL. Pathogenesis, diagnosis and management of heparin-induced thrombocytopenia. Heartland Hospital CME Dinner, Sebring, FL, October 24th, 2001.
Francis JL. Pathogenesis of thrombosis in cancer. Hemostasis and Cancer Conference, Dartmouth-Hitchcock Medical Center, Lebanon, NH, October 19th, 2001.
Francis JL. Pathogenesis, diagnosis and management of heparin-induced thrombocytopenia. Nursing Education Department, Osceola Medical Center, Kissimmee, FL, October, 2001.
Francis JL. Hemostasis and Cancer. Anticoagulation in Thrombosis meeting, Celebration Heath, Celebration, FL, September 21st, 2001.
Francis JL. Pathogenesis, diagnosis and management of heparin-induced thrombocytopenia. Medical Education Systems CME, Tampa, September 20th, 2001.
Francis JL. Pathogenesis, diagnosis and management of heparin-induced thrombocytopenia. Surgical Department Meeting, Osceola Medical Center, Kissimmee, FL, September 17th, 2001.
Francis JL. Clinical Applications of the PFA-100 Platelet Function Analyzer. Surgical Grand Rounds. Baylor Medical Center, Dallas, TX, July 25th, 2001.
Francis JL. Hemostasis and Cancer: New Angles on an Old Story. "Be a Believer" 2001 Coagulation Tour, Sigma Diagnostics, Minneapolis, MN, June 12th, 2001.
Francis JL. Laboratory Investigation of Thrombophilia. "Be a Believer" 2001 Coagulation Tour, Sigma Diagnostics, Minneapolis, MN, June 12th, 2001.
Francis JL. Case Studies in Heparin-Induced Thrombocytopenia. Faculty Development Meeting, Medical Education Systems, Captiva Island, FL, May 19th, 2001.
Francis JL. Pathogenesis, diagnosis and management of heparin-induced thrombocytopenia. Florida Association of Blood Banks 55th Annual Conference. Orlando, FL, May 10th, 2001.
Francis JL. Pathogenesis and diagnosis of heparin-induced thrombocytopenia. Regional Ambassador Meeting, Medical Education Systems, Tampa, FL, May 5th, 2001
Francis JL. Pathogenesis and diagnosis of heparin-induced thrombocytopenia. Regional Ambassador Meeting, Medical Education Systems, Atlanta, GA, April 21st, 2001.
Francis JL. Pathogenesis and diagnosis heparin-induced thrombocytopenia. Regional Ambassador Meeting, Medical Education Systems, Dallas, TX, April 7th, 2001.
Francis JL. Pathogenesis and diagnosis heparin-induced thrombocytopenia. Regional Ambassador Meeting, Medical Education Systems, Philadelphia, PA, March 31st, 2001.
Francis JL. Pathogenesis, Diagnosis and Management of heparin-induced thrombocytopenia. Grand Rounds, Naples Community Hospital, Naples, FL, March 23rd, 2001.
Francis JL. Pathogenesis, Diagnosis and Management of heparin-induced thrombocytopenia. GlaxoSmithKline, Hilton Head, SC, March 17th, 2001.
Francis JL. Pathogenesis, diagnosis and management of heparin-induced thrombocytopenia. GlaxoSmithKline, Stuart, FL, March 1st, 2001.
Francis JL. Pathogenesis, diagnosis and management of heparin-induced thrombocytopenia. GlaxoSmithKline, Orlando, FL, February 22nd, 2001.
Francis JL. Pathogenesis, diagnosis and management of heparin-induced thrombocytopenia. GlaxoSmithKline, Ormond Beach, FL, February 7th, 2001.
Francis JL. Laboratory testing and screening for heparin-induced thrombocytopenia. Argatroban Core Curriculum Planning Meeting, GlaxoSmithKline. Dallas, TX, January 8-10, 2001.
2000
Francis JL. Heparin-Induced Thrombocytopenia: Pathophysiology, Diagnosis and Management. SmithKline Beecham, Orlando, FL, December 14, 2000.
Francis JL. Evaluation of the Thrombophilic Patient. Florida West Coast Association of Pathologists, St. Joseph’s Hospital, Tampa, FL, December 9, 2000
Francis JL. Heparin-Induced Thrombocytopenia: Pathophysiology, Diagnosis and Management. SmithKline Beecham Medical Advisory Board, Orlando, November 18, 2000.
Francis JL. Clinical application of the Platelet Function Analyzer (PFA)-100 test. Northwestern Memorial Hospital, Chicago, October 27, 2000.
Francis JL. Clinical application of the Platelet Function Analyzer (PFA)-100 test. Northwestern Memorial Hospital, Chicago, October 26, 2000.
Francis JL. Heparin-Induced Thrombocytopenia: Pathophysiology, Diagnosis and Management. Cardiology Grand Rounds. Regional Medical Center, Bayonet Point, F, October 12, 2000.
Francis JL. Clinical application of the Platelet Function Analyzer (PFA)-100 test. Rochester, NY, October 4, 2000.
Francis JL. Clinical application of the Platelet Function Analyzer (PFA)-100 test. 1st International Dade-Behring Coagulation Conference. Saville, Spain, September 20-22, 2000.
Francis JL. Hemostasis and Cancer. Sigma Hemostasis Symposium, Miami, FL, September 12, 2000.
Francis JL. Laboratory investigation of hypercoagulability. Sigma Hemostasis Symposium, Miami, FL, September 12, 2000.
Francis JL. Laboratory testing and screening for heparin-induced thrombocytopenia. SmithKline Beecham Advisory Meeting on Argatroban, Newport Beach, CA, August 10, 2000.
Francis JL. Clinical experience with the Platelet Function Analyzer (PFA-100). Platelets 2000 Symposium Ma’ale Hachimisha, Israel, May 20, 2000.
Francis JL. Whole blood approaches to the study of clot formation. Speywood Pharmaceuticals Scientific Advisory Meeting, Las Vegas, NV, May 11, 2000.
Francis JL. Clinical experience with the Platelet Function Analyzer (PFA-100). 33rd Alabama State Society for Clinical Laboratory Science 2000 Annual Meeting, Mobile, AL, April 7, 2000.
Francis JL. Platelet Function assessment with the (PFA-100). Dade-Behring Hemostasis Spring Series, Houston, TX, March 28, 2000
Francis JL. Platelet Function assessment with the (PFA-100). Dade-Behring Hemostasis Spring Series, San Francisco, CA, March 8, 2000.
1999
Francis JL. Hemostasis and Cancer. Sunol Molecular Corp., Miramar, FL, December 8, 1999.
Francis JL. Case Studies in Heparin-Induced Thrombocytopenia and Thrombosis. Helena Laboratories Hemostasis Update Series, Tampa, FL, November 15, 1999.
Francis JL. Application of the Platelet Function Analyzer (PFA-100) in Clinical Practice. 33rd Penner Blood Coagulation Conference, Maui, HI, October 21, 1999.
Francis JL. Heparin-Induced Thrombocytopenia and Thrombosis. 33rd Penner Blood Coagulation Conference, Maui, HI, October 20, 1999.
Francis JL. Use and Interpretation of the PFA-100 Test. CME Lecture. Licking Memorial Hospital, Newark, Ohio, September 20, 1999.
Francis JL. Comparison of PFA-100® and Bleeding Time in Detection of Platelet Dysfunction. Dade-Behring Summer Series Hemostasis Course. Atlanta, GA, June 9, 1999.
Francis JL. Heparin-induced thrombocytopenia. Cardiology Grand Rounds, Tampa General Hospital, Tampa, FL, May 26, 1999.
Francis JL. Heparin-induced thrombocytopenia. Jackson Memorial Hospital, Miami, FL, April 30, 1999.
Francis JL. Current issues with heparin: Monitoring and complications. North Dakota Association of Medical Laboratory Technology Annual Meeting. Minot, ND, April 22, 1999.
Francis JL. Comparison of PFA-100® and Bleeding Time in Detection of Platelet Dysfunction. North Dakota Association of Medical Laboratory Technology Annual Meeting. Minot, ND, April 22, 1999.
Francis JL. Pathogenesis of Cancer Associated Thrombosis. 3rd Annual Winter Oncology Conference. Supportive Care in Cancer. Whistler, British Columbia, Canada. March 19, 1999.
1998
Francis JL. Comparison of PFA-100® and Bleeding Time in Detection of Platelet Dysfunction. Advances in Platelet Function ’98. American Society for Hematology Annual Meeting, Miami Beach, December 4, 1998.
Francis JL. Recent Advances in Platelet Function Analysis. Gulf Coast Chapter CLMA 1st Annual Meeting, Sarasota, FL, October 16, 1998.
Francis JL. Recent Advances in Platelet Function Analysis. Dade-Behring Hemostasis Educational Seminar, Honolulu, HI, September 16, 1998.
Francis JL. Recent Advances in Platelet Function Analysis. Dade-Behring Hemostasis Educational Seminar, New Orleans, June 10, 1998.
Francis JL. Hypercoagulability in Malignant Disease. 2nd International Symposium on Thrombosis, Haemostasis and Vascular Biology. Porto, Portugal, 5-6 June, 1998.
Francis JL. Whole Blood Approach to the investigation of Hemostatic Disorders. 32nd Annual Penner Blood Coagulation Conference, Las Vegas, May 9-15, 1998.
Francis JL. Tissue Factor and Cancer. 32nd Annual Penner Blood Coagulation Conference, Las Vegas, May 9-15, 1998.
1997
Francis JL. Hemostasis and Cancer. ME/NH Medical Technologists. Portland, ME, October 16, 1997.
Francis JL. Laboratory Approach to the Diagnosis of Hypercoagulability. ME/NH Medical Technologists. Portland, ME, October 16, 1997.
Francis JL. Hemostasis and Cancer: From Trousseau’s Syndrome to Angiogenesis. Current Treatment and Future Directions in the Management of Breast and Lung Cancer. Orlando, FL. July 1997.
Francis JL. Fibrin monomer increases platelet adherence to tumor cells in a flowing system. Xylum Symposium, ISTH Florence, June 1997.
1996
Francis JL. Hemostasis and Cancer. Pharmacia Hepar Symposium on Hypercoagulability. American Society of Hematology, Orlando, December 1996.
Francis JL. Hemostasis and Cancer. Sysmex Users’ Group Meeting, Leicester, UK. November 1996.
Francis JL. Hemostasis and Cancer. American Society of Clinical Pathologists Teleconference. October 1996.
Francis JL. Aprotinin in Neurosurgery. Aprotinin and Lysine Analogs in the Control of Medical and Surgical Bleeding. International Society for Fibrinolysis. Barcelona, Spain. June 1996.
Francis JL. Laboratory Diagnosis of Hypercoagulability. 30th Penner Conference on Blood Coagulation. Hawaii, May 1996.
Francis JL. Hemostasis and Cancer. 30th Penner Conference on Blood Coagulation. Hawaii, May 1996.
Francis JL. Hemostasis and Cancer. International Society for Laboratory Hematology, Banff, Canada. April 1996.
Francis JL. Hemostasis and Cancer. Coalition of Clinical Laboratories Medical Laboratory Association. Orlando, March 1996.
Francis JL. Hemostasis and Cancer. CME Lecture Series, Lakeland Memorial Hospital, Lakeland, Florida, February, 1996.
1995
Francis JL. The Biology of Metastasis. Visiting Nurses Association. Orlando, October 1995.
Francis JL. Hemostasis and Cancer. EntreMed Inc., Rockville, MD, August 1995.
Francis JL. Hemostasis and Cancer. Seventh Annual Lectures in Contemporary Hemostasis and Thrombosis, Miami University School of Medicine, March 1995.
Francis JL. Hemostasis and Cancer. Hem-Oncology Grand Rounds, Miami University School of Medicine, March 1995.
Francis JL. Hypercoagulability. Coulter Countdown Lecture Series. San Francisco, February 1995.
Francis JL. Hypercoagulability. Coulter Countdown Lecture Series. Cincinnati, January 1995.
Francis JL. Hypercoagulability. Coulter Countdown Lecture Series. Chicago, January 1995.
1994
Francis JL. Hypercoagulability. Coulter Countdown Lecture Series. Boston, December 1994.
Francis JL. Hypercoagulability. Coulter Countdown Lecture Series. Philadelphia, November 1994.
Francis JL. Hypercoagulability. Coulter Countdown Lecture Series. Houston, November 1994.
Francis JL. Hypercoagulability. Coulter Countdown Lecture Series. Dallas, October 1994.
Francis JL. Hypercoagulability. Coulter Countdown Lecture Series. New York, October 1994.
Francis JL. Hypercoagulability. Coulter Countdown Lecture Series. Baltimore, October 1994.
Francis JL. Hypercoagulability. Coulter Countdown Lecture Series. Fort Lauderdale, September 1994.
